HRP20010529B1 - 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors - Google Patents

2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors

Info

Publication number
HRP20010529B1
HRP20010529B1 HR20010529A HRP20010529A HRP20010529B1 HR P20010529 B1 HRP20010529 B1 HR P20010529B1 HR 20010529 A HR20010529 A HR 20010529A HR P20010529 A HRP20010529 A HR P20010529A HR P20010529 B1 HRP20010529 B1 HR P20010529B1
Authority
HR
Croatia
Prior art keywords
monosaccharides
cell adhesion
adhesion inhibitors
isopropylidene derivatives
isopropylidene
Prior art date
Application number
HR20010529A
Other languages
English (en)
Inventor
K. Arora Sudershan
Kishore Nawal
Bahadur Gupta Jang
D. Joshi Vishwas
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of HRP20010529A2 publication Critical patent/HRP20010529A2/hr
Publication of HRP20010529B1 publication Critical patent/HRP20010529B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HR20010529A 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors HRP20010529B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (OSRAM) 1999-01-15 1999-01-15
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors
PCT/IB2000/000022 WO2000042054A1 (en) 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors

Publications (2)

Publication Number Publication Date
HRP20010529A2 HRP20010529A2 (en) 2002-08-31
HRP20010529B1 true HRP20010529B1 (en) 2005-02-28

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010529A HRP20010529B1 (en) 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors

Country Status (30)

Country Link
US (5) US6590085B1 (OSRAM)
EP (1) EP1147119B1 (OSRAM)
JP (1) JP2002534530A (OSRAM)
CN (1) CN1167707C (OSRAM)
AR (1) AR022235A1 (OSRAM)
AT (1) ATE250074T1 (OSRAM)
AU (1) AU768511B2 (OSRAM)
BG (1) BG105745A (OSRAM)
BR (1) BR0007553A (OSRAM)
CA (1) CA2359986A1 (OSRAM)
CO (1) CO5180591A1 (OSRAM)
CR (1) CR6423A (OSRAM)
CZ (1) CZ20012540A3 (OSRAM)
DE (1) DE60005300T2 (OSRAM)
DK (1) DK1147119T3 (OSRAM)
ES (1) ES2206176T3 (OSRAM)
HR (1) HRP20010529B1 (OSRAM)
HU (1) HUP0105116A3 (OSRAM)
ID (1) ID30351A (OSRAM)
IN (1) IN190975B (OSRAM)
MA (1) MA25342A1 (OSRAM)
MX (1) MXPA01007187A (OSRAM)
MY (1) MY121135A (OSRAM)
NZ (2) NZ527483A (OSRAM)
PA (1) PA8489901A1 (OSRAM)
PT (1) PT1147119E (OSRAM)
SK (1) SK284241B6 (OSRAM)
TR (1) TR200102043T2 (OSRAM)
WO (1) WO2000042054A1 (OSRAM)
YU (1) YU50701A (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (OSRAM) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
CN1812983A (zh) 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
US20090221515A1 (en) * 2004-09-02 2009-09-03 Viswajanani Jitendra Sattigeri Monosaccharide derivatives
JP2008525421A (ja) * 2004-12-22 2008-07-17 ランバクシー ラボラトリーズ リミテッド モノサッカリド誘導体
EP1915160A2 (en) * 2005-07-22 2008-04-30 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
US20080114031A1 (en) * 2006-03-29 2008-05-15 Sattigeri Viswajanani J Monosaccharide derivatives
EP1864992A2 (en) * 2006-05-30 2007-12-12 Ranbaxy Laboratories, Ltd. Monosaccharide derivatives
EP1953170A1 (en) * 2006-10-03 2008-08-06 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-inflammatory agents
AU2008221506B2 (en) * 2007-09-20 2011-01-20 ResMed Pty Ltd Retractable Tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) * 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (OSRAM) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
ID30351A (id) 2001-11-22
HUP0105116A3 (en) 2003-05-28
IN190975B (OSRAM) 2003-09-06
CN1167707C (zh) 2004-09-22
ES2206176T3 (es) 2004-05-16
BR0007553A (pt) 2001-12-18
CR6423A (OSRAM) 2004-03-09
HRP20010529A2 (en) 2002-08-31
WO2000042054A1 (en) 2000-07-20
EP1147119A1 (en) 2001-10-24
US7005422B2 (en) 2006-02-28
MY121135A (en) 2005-12-30
US20040018995A1 (en) 2004-01-29
HUP0105116A2 (hu) 2003-04-28
TR200102043T2 (tr) 2001-11-21
AU1886100A (en) 2000-08-01
US20040019191A1 (en) 2004-01-29
HK1041270A1 (en) 2002-07-05
NZ512852A (en) 2004-02-27
NZ527483A (en) 2005-02-25
BG105745A (en) 2002-05-31
YU50701A (sh) 2005-06-10
CA2359986A1 (en) 2000-07-20
US6590085B1 (en) 2003-07-08
MA25342A1 (fr) 2001-12-31
CN1343213A (zh) 2002-04-03
SK284241B6 (en) 2004-11-03
PT1147119E (pt) 2004-02-27
EP1147119B1 (en) 2003-09-17
US20040029820A1 (en) 2004-02-12
AU768511B2 (en) 2003-12-18
DK1147119T3 (da) 2004-01-19
SK10132001A3 (sk) 2002-01-07
US20040023900A1 (en) 2004-02-05
CZ20012540A3 (cs) 2002-02-13
US7037899B2 (en) 2006-05-02
CO5180591A1 (es) 2002-07-30
US7005516B2 (en) 2006-02-28
DE60005300T2 (de) 2004-07-15
PA8489901A1 (es) 2000-09-29
DE60005300D1 (de) 2003-10-23
AR022235A1 (es) 2002-09-04
JP2002534530A (ja) 2002-10-15
ATE250074T1 (de) 2003-10-15
MXPA01007187A (es) 2002-04-24

Similar Documents

Publication Publication Date Title
AU6903200A (en) Heterocycle amides as cell adhesion inhibitors
AU5152100A (en) Substituted beta-alanine derivatives as cell adhesion inhibitors
AU8059598A (en) Heterocyclic amide compounds as cell adhesion inhibitors
IL149651A0 (en) N6 heterocyclic 8-modified adenosine derivatives
IL112756A0 (en) Sulfated alfa-glycolipid derivatives as cell adhesion inhibitors
HUP0202450A3 (en) N-heterocyclic derivatives as nos inhibitors
AU1463499A (en) Substituted pyrrole derivatives as cell adhesion inhibitors
AU6909300A (en) Substituted ureas as cell adhesion inhibitors
PL364926A1 (en) Heterocyclic dihydropyrimidines as potassium channel inhibitors
EP0743951A4 (en) SUBSTITUTED LACTOSE DERIVATIVES AS CELL ADHESION INHIBITORS
IL144274A0 (en) Derivatives of monosaccharides as cell adhesion inhibitors
PL355099A1 (en) Pyrrole derivatives as phosphodiesterase vii inhibitors
AU2055201A (en) N6 heterocyclic 5' modified adenosine derivatives
PL355022A1 (en) Imidazopyridine derivatives as phosphodiesterase vii inhibitors
PL352296A1 (en) Crystalline derivatives of 1-methylocarbapeneme
GB0017279D0 (en) Amides as cell adhesion inhibitors
IL147245A0 (en) Substituted purine derivatives as inhibitors of cell adhesion
AU2690600A (en) 2-mercaptocarboxylic acid derivatives
DK1147119T3 (da) 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer
PL355020A1 (en) Imidazole derivatives as phosphodiesterase vii inhibitors
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
IL112734A0 (en) Sulfated beta-glycolipid derivatives as cell adhesion inhibitors
IL144273A0 (en) 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
IL150010A0 (en) Heterocyclic derivatives
AU5652499A (en) Heterocyclic derivatives having acaricidal activity

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20060110

Year of fee payment: 7

PBON Lapse due to non-payment of renewal fee

Effective date: 20070111